KRISTIN LANDRUM: Open Payments
NPI 1366026718 · SPRINGFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 33 payments from 15 companies in 2025. Trend: 2023 $208 · 2024 $160 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $75 |
| Esperion Therapeutics, Inc. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Abbott Laboratories | 2 | $38 |
| Novo Nordisk Inc | 2 | $37 |
| Dexcom, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Verona Pharma, Inc. | 1 | $26 |
Products named: Kerendia, BREZTRI, FARXIGA, NEXLETOL, CAPLYTA, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across OH — which companies pay providers there.
